Remdesivir
Remdesivir, sold under the brand name Veklury, is a broad-spectrum antiviral medication developed by the biopharmaceutical company Gilead Sciences. The most common side effects in people with COVID‑19 is nausea. The expected course of treatment is six vials over five days for a total cost of US$2,340.